Cystic fibrosis, a genetic disorder, affects lungs and other organs. It causes thick mucus buildup. Researchers have ...

Building on positive Phase 2 data, Puretech plans to launch a Phase 3 trial to further evaluate its experimental IPF therapy ...

The expanded partnership will give Equinox members preferred access to Function through exclusive pricing and program-integrated offerings that support long-term health. Equinox members will gain ...

That observation was prompted by a visit to the walk-in storage cooler inside the Blood Bank in UAB Hospital. If you are squeamish at the sight of blood, this is not the place for you. When the door ...

The U.K. company presented findings that its 360 e-Lung technology could potentially speed up the diagnosis of progressive pulmonary fibrosis by nearly two years in more than half of the patients ...

Lung cancer is a formidable disease that affects people from all walks of life. While the disease is often associated with ...

The GOLD 2024/2025 reports underscore the importance of spirometry in confirming a COPD diagnosis, with a post-bronchodilator ...

Researching IPF after her late husband's diagnosis meant learning many new acronyms and abbreviations, says guest writer.

SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today ...

Credit: Getty Images The road to race-neutral pulmonary function testing has been long and evolving; now, ATS recommends this approach and a Boston hospital offers an implementation model. In July, ...

Tectonic Therapeutic plans to launch a Phase 2 clinical trial to test the impact of its therapy candidate TX45 on blood flow, or hemodynamics, in people with pulmonary hypertension and interstitial ...